All Phenotypes Tg(Mpz-cre)3Brn MGI Mouse

Phenotypes associated with this allele

Jump to	Allelic Composition	Genetic Background	Genotype ID
cn1	Nf2^tm2Gth/Nf2^tm2Gth Trp53^tm1Brd/Trp53⁺ Tg(Mpz-cre)3Brn/0	involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N	MGI:3850409
cn2	Nf2^tm2Gth/Nf2⁺ Trp53^tm1Brd/Trp53⁺ Tg(Mpz-cre)3Brn/0	involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N	MGI:3850410
cn3	Nf2^tm2Gth/Nf2^tm2Gth Tg(Mpz-cre)3Brn/0	involves: 129P2/OlaHsd * FVB/N	MGI:3850390
cn4	Nf2^tm1Gth/Nf2^tm2Gth Tg(Mpz-cre)3Brn/0	involves: 129P2/OlaHsd * FVB/N	MGI:3850395

Allelic Composition	Nf2^tm2Gth/Nf2^tm2Gth Trp53^tm1Brd/Trp53⁺ Tg(Mpz-cre)3Brn/0
Genetic Background	involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nf2^tm2Gth mutation (3 available); any Nf2 mutation (65 available)
Tg(Mpz-cre)3Brn mutation (0 available)
Trp53^tm1Brd mutation (5 available); any Trp53 mutation (232 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

decreased survivor rate ( J:92413 )

premature death ( J:92413 )

• 4 of 12 mice die prematurely due to malignant peripheral nerve sheath tumors, 3 of which are 5 months old

neoplasm

increased neurofibrosarcoma incidence ( J:92413 )

• in 4 of 12 mice

nervous system

increased neurofibrosarcoma incidence ( J:92413 )

• in 4 of 12 mice

Allelic Composition	Nf2^tm2Gth/Nf2⁺ Trp53^tm1Brd/Trp53⁺ Tg(Mpz-cre)3Brn/0
Genetic Background	involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N

Find Mice

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

premature death ( J:92413 )

• mice exhibit a decrease in survival rate when the Nf2 and Trp53 alleles are carried in cis as opposed to trans, but live longer than conditional mutants carrying Tg(P0-Cre)2Gth

neoplasm

increased neurofibrosarcoma incidence ( J:92413 )

• between 3.5 and 13.5 months,19% of mice develop malignant peripheral nerve sheath tumors when the Nf2 and Trp53 alleles are carried in cis

• however, no tumors form in mice when the Nf2 and Trp53 alleles are carried in trans

increased skeletal tumor incidence ( J:92413 )

• when the Nf2 and Trp53 alleles are carried in trans mice develop osteogenic tumors not restricted to neural crest-derived bone

increased osteosarcoma incidence ( J:92413 )

• 81% of mice develop osteogenic (osteomas and osteosarcomas) tumors when the Nf2 and Trp53 alleles are carried in cis

increased osteoma incidence ( J:92413 )

• 81% of mice develop osteogenic (osteomas and osteosarcomas) tumors when the Nf2 and Trp53 alleles are carried in cis

skeleton

increased skeletal tumor incidence ( J:92413 )

• when the Nf2 and Trp53 alleles are carried in trans mice develop osteogenic tumors not restricted to neural crest-derived bone

increased osteosarcoma incidence ( J:92413 )

• 81% of mice develop osteogenic (osteomas and osteosarcomas) tumors when the Nf2 and Trp53 alleles are carried in cis

increased osteoma incidence ( J:92413 )

• 81% of mice develop osteogenic (osteomas and osteosarcomas) tumors when the Nf2 and Trp53 alleles are carried in cis

nervous system

increased neurofibrosarcoma incidence ( J:92413 )

• between 3.5 and 13.5 months,19% of mice develop malignant peripheral nerve sheath tumors when the Nf2 and Trp53 alleles are carried in cis

• however, no tumors form in mice when the Nf2 and Trp53 alleles are carried in trans

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased fibroadenoma incidence ( J:63264 )

• 12% of mice exhibit fibroadenoma in the mammary gland

osseous metaplasia ( J:63264 )

• 30% of mice develop osseous metaplasia

increased lung adenocarcinoma incidence ( J:63264 )

• in 12% in mice

increased renal carcinoma incidence ( J:63264 )

• 18% of mice develop carcinoma in situ in the kidney

increased sarcoma incidence ( J:63264 )

• 30% of mice develop stromal sarcoma

increased neurofibrosarcoma incidence ( J:63264 )

• 6% of mice develop neurofibrosarcoma

increased osteosarcoma incidence ( J:63264 )

• in 6% of mice

increased odontoma incidence ( J:63264 )

• 6% of mice exhibit odontoma

increased Schwannoma incidence ( J:63264 , J:92413 )

• 30% of mice develop osseous metaplasia (J:63264)

• 6% of mice exhibit odontoma (J:63264)

• 35% of mice develop schwannomas (J:92413)

increased osteoma incidence ( J:63264 )

• 6% of mice develop osteoma

skeleton

abnormal tooth development ( J:63264 )

• 12% of mice exhibit odontoblastic hyperplasia

increased osteosarcoma incidence ( J:63264 )

• in 6% of mice

increased osteoma incidence ( J:63264 )

• 6% of mice develop osteoma

abnormal osteoblast morphology ( J:63264 )

• osteogenic hyperplasia in 47% of mice

nervous system

increased neurofibrosarcoma incidence ( J:63264 )

• 6% of mice develop neurofibrosarcoma

increased Schwannoma incidence ( J:63264 , J:92413 )

• 30% of mice develop osseous metaplasia (J:63264)

• 6% of mice exhibit odontoma (J:63264)

• 35% of mice develop schwannomas (J:92413)

abnormal Schwann cell morphology ( J:63264 )

• 82% of mice exhibit Schwann cell hyperplasia

renal/urinary system

increased renal carcinoma incidence ( J:63264 )

• 18% of mice develop carcinoma in situ in the kidney

abnormal renal tubule morphology ( J:63264 )

• 53% of mice exhibit renal tubular cell hyperplasia

vision/eye

cataract ( J:63264 )

• in 14% to 18% of mice, in which 50% of cases are bilateral

craniofacial

abnormal tooth development ( J:63264 )

• 12% of mice exhibit odontoblastic hyperplasia

growth/size/body

abnormal tooth development ( J:63264 )

• 12% of mice exhibit odontoblastic hyperplasia

respiratory system

increased lung adenocarcinoma incidence ( J:63264 )

• in 12% in mice

integument

increased fibroadenoma incidence ( J:63264 )

• 12% of mice exhibit fibroadenoma in the mammary gland

endocrine/exocrine glands

increased fibroadenoma incidence ( J:63264 )

• 12% of mice exhibit fibroadenoma in the mammary gland

Allelic Composition	Nf2^tm1Gth/Nf2^tm2Gth Tg(Mpz-cre)3Brn/0
Genetic Background	involves: 129P2/OlaHsd * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Nf2^tm1Gth mutation (1 available); any Nf2 mutation (65 available)
Nf2^tm2Gth mutation (3 available); any Nf2 mutation (65 available)
Tg(Mpz-cre)3Brn mutation (0 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

mortality/aging

decreased survivor rate ( J:63264 )

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 04/16/2024 MGI 6.23